Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Houlihan Lokey raises quarterly dividend to 33c per share from 31c » 16:22
07/28/20
07/28
16:22
07/28/20
16:22
HLI

Houlihan Lokey

$55.95 /

-0.025 (-0.04%)

The Board of Directors of…

The Board of Directors of the Company declared a regular quarterly cash dividend of $0.33 per share of Class A and Class B common stock, an increase from the previous dividend rate of $0.31 per share. The dividend will be payable on September 15, 2020 to stockholders of record as of the close of business on September 2, 2020.

ShowHide Related Items >><<
HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

07/22/20 Wolfe Research
Houlihan Lokey initiated with a Peer Perform at Wolfe Research
07/10/20 JPMorgan
Houlihan Lokey downgraded to Neutral from Overweight at JPMorgan
06/25/20 JMP Securities
Financial impact of Houlihan Lokey deal 'quite modest,' says JMP Securities
01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

  • 19
    May
  • 30
    Jul
Earnings
Houlihan Lokey reports Q1 adjusted EPS 56c, consensus 57c » 16:21
07/28/20
07/28
16:21
07/28/20
16:21
HLI

Houlihan Lokey

$55.95 /

-0.025 (-0.04%)

Reports Q1 revenue…

Reports Q1 revenue $211.14M, consensus $234.06M. "The business environment continues to present many challenges, but also opportunities. Our Financial Restructuring and Capital Markets businesses are performing well, partially offsetting lower Merger & Acquisition activity, which is down along with the global M&A market. This dynamic is similar to previous economic downturns, where for a few quarters, we experienced restructuring growth that partially offsets a decrease in corporate finance. As the cycle extends, restructuring growth has the potential to fully offset the decrease in corporate finance. This balanced business model enables us to maintain long-term confidence in our results, it keeps our employees busy through the cycles and it allows us to exit any distressed environment better positioned than when we went in. I want to thank our employees who have worked remotely and tirelessly for months and our clients who have put their trust in us during these tumultuous times," stated Scott Beiser, Chief Executive Officer of Houlihan Lokey.

ShowHide Related Items >><<
HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

07/22/20 Wolfe Research
Houlihan Lokey initiated with a Peer Perform at Wolfe Research
07/10/20 JPMorgan
Houlihan Lokey downgraded to Neutral from Overweight at JPMorgan
06/25/20 JMP Securities
Financial impact of Houlihan Lokey deal 'quite modest,' says JMP Securities
01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
HLI Houlihan Lokey
$55.95 /

-0.025 (-0.04%)

  • 19
    May
  • 30
    Jul
Initiation
Houlihan Lokey initiated with a Peer Perform at Wolfe Research » 09:03
07/22/20
07/22
09:03
07/22/20
09:03
HLI

Houlihan Lokey

$57.12 /

+0.035 (+0.06%)

Wolfe Research analyst…

Wolfe Research analyst Steven Chubak initiated coverage of boutique advisors at Market Underweight for the group, starting Houlihan Lokey with a Peer Perform rating and $60 price target.

ShowHide Related Items >><<
HLI Houlihan Lokey
$57.12 /

+0.035 (+0.06%)

HLI Houlihan Lokey
$57.12 /

+0.035 (+0.06%)

07/10/20 JPMorgan
Houlihan Lokey downgraded to Neutral from Overweight at JPMorgan
06/25/20 JMP Securities
Financial impact of Houlihan Lokey deal 'quite modest,' says JMP Securities
01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
HLI Houlihan Lokey
$57.12 /

+0.035 (+0.06%)

  • 19
    May
  • 30
    Jul
Downgrade
Houlihan Lokey downgraded to Neutral from Overweight at JPMorgan » 07:14
07/10/20
07/10
07:14
07/10/20
07:14
HLI

Houlihan Lokey

$55.39 /

-0.825 (-1.47%)

JPMorgan analyst Kenneth…

JPMorgan analyst Kenneth Worthington downgraded Houlihan Lokey to Neutral from Overweight with a $57 price target. The analyst sees a balanced risk/reward at current share levels.

ShowHide Related Items >><<
HLI Houlihan Lokey
$55.39 /

-0.825 (-1.47%)

HLI Houlihan Lokey
$55.39 /

-0.825 (-1.47%)

06/25/20 JMP Securities
Financial impact of Houlihan Lokey deal 'quite modest,' says JMP Securities
01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
HLI Houlihan Lokey
$55.39 /

-0.825 (-1.47%)

  • 19
    May
  • 30
    Jul
Over a month ago
Recommendations
Financial impact of Houlihan Lokey deal 'quite modest,' says JMP Securities » 14:15
06/25/20
06/25
14:15
06/25/20
14:15
HLI

Houlihan Lokey

$55.28 /

-0.96 (-1.71%)

After Houlihan Lokey…

After Houlihan Lokey announced the acquisition of TMT focused independent advisory firm MVP Capital, JMP Securities analyst Devin Ryan noted that the company has suggested over the past few months that it was looking at an acquisition a bit larger than its normal tuck-in deals. Making "some (very) rough assumptions," he estimates MVP generates around $30M in revenue, which would imply a price of around $75M at the midpoint if Houlihan Lokey is paying in the range of two to three times revenue, Ryan tells investors. The analyst, who projects that the financial impact of the deal "is quite modest," keeps a Market Perform rating on Houlihan Lokey shares

ShowHide Related Items >><<
HLI Houlihan Lokey
$55.28 /

-0.96 (-1.71%)

HLI Houlihan Lokey
$55.28 /

-0.96 (-1.71%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$55.28 /

-0.96 (-1.71%)

Hot Stocks
Houlihan Lokey to acquire MVP Capital » 08:34
06/25/20
06/25
08:34
06/25/20
08:34
HLI

Houlihan Lokey

$56.24 /

-1.07 (-1.87%)

Houlihan Lokey has agreed…

Houlihan Lokey has agreed to acquire MVP Capital, an independent advisory firm that provides a range of advisory services to clients in the technology, media, and telecom, or TMT, sector. Houlihan Lokey said in a release, "The transaction, signed June 23, adds substantially to the firm's coverage of the telecommunications sector and expands Houlihan Lokey's footprint in the U.S. The transaction is expected to be completed next quarter following regulatory approval. As part of this transaction, MVP's investment banking team will become part of Houlihan Lokey's global TMT Group. Jason Hill, MVP Managing Partner, will join as a co-head alongside Rob Louv and Roy Kabla, who currently lead the firm's team. In addition, MVP CEO Greg Widroe will assume a senior role in the TMT Group, focusing in part on strategic initiatives. The acquisition will add 25 financial professionals to Houlihan Lokey's TMT Group, including MVP's seven managing directors, bringing the global TMT team to more than 60 financial professionals."

ShowHide Related Items >><<
HLI Houlihan Lokey
$56.24 /

-1.07 (-1.87%)

HLI Houlihan Lokey
$56.24 /

-1.07 (-1.87%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$56.24 /

-1.07 (-1.87%)

Syndicate
Houlihan Lokey 3M share Spot Secondary priced at $63.50 » 20:46
05/18/20
05/18
20:46
05/18/20
20:46
HLI

Houlihan Lokey

$64.30 /

+2.26 (+3.64%)

The deal priced at low…

The deal priced at low end of $63.50-$64.00 range. Goldman Sachs is acting as sole book running manager for the offering.

ShowHide Related Items >><<
HLI Houlihan Lokey
$64.30 /

+2.26 (+3.64%)

HLI Houlihan Lokey
$64.30 /

+2.26 (+3.64%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$64.30 /

+2.26 (+3.64%)

  • 19
    May
Syndicate
Houlihan Lokey announces offering of 3M shares of common stock » 16:29
05/18/20
05/18
16:29
05/18/20
16:29
HLI

Houlihan Lokey

$64.31 /

+2.27 (+3.66%)

Houlihan Lokey announced…

Houlihan Lokey announced an underwritten public offering of 3M shares of its Class A common stock. The company intends to use the net proceeds from the offering for general corporate purposes, which may include funding potential future acquisitions. Goldman Sachs is acting as the sole underwriter for the offering.

ShowHide Related Items >><<
HLI Houlihan Lokey
$64.31 /

+2.27 (+3.66%)

HLI Houlihan Lokey
$64.31 /

+2.27 (+3.66%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$64.31 /

+2.27 (+3.66%)

Hot Stocks
Houlihan Lokey says Q4 revenues were negatively impacted by COVID-19 » 16:16
05/12/20
05/12
16:16
05/12/20
16:16
HLI

Houlihan Lokey

$59.90 /

-2.57 (-4.11%)

"The COVID-19…

"The COVID-19 pandemic has had a substantial negative effect on the global markets, and has created uncertainty, volatility and dislocation among a wide variety of sectors," the company said. "The scale, scope and duration of the impact of the COVID-19 pandemic on our business, revenues and operating results is unpredictable and depends on many factors outside of our control. We note that revenues during the fourth quarter ended March 31, 2020 were negatively impacted by the COVID-19 pandemic and we expect it to continue to have an adverse effect on our business, revenues and operating results in the short term. However, while our CF revenues will be adversely impacted for an indeterminable period of time by the economic effects of COVID-19, we have seen an increase in the demand for services in our FR business."

ShowHide Related Items >><<
HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

Earnings
Houlihan Lokey reports Q4 adjusted EPS 96c, consensus 77c » 16:15
05/12/20
05/12
16:15
05/12/20
16:15
HLI

Houlihan Lokey

$59.90 /

-2.57 (-4.11%)

Reports Q4 revenue $303M,…

Reports Q4 revenue $303M, consensus $289.09M. "Concluding a fiscal year of record performance is a point of pride for all within our organization. It remains a tremendous accomplishment, but needless to say, our attention quickly turned to the onset of the COVID-19 crisis and the pronounced drop-off in global economic activity. While we enter this period of uncertainty in as strong of a financial and strategic position as we have ever been, challenges, no doubt, lie ahead for us, the economy and the world as a whole. Notwithstanding this rapidly evolving and uncertain environment, we have an advantage in that we built our business to perform during all cycles. Though cyclical disruptions take time to work themselves through our reported results, we are confident that our business will emerge from this crisis stronger than ever," stated Scott Beiser, Chief Executive Officer of Houlihan Lokey.

ShowHide Related Items >><<
HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/26/20 Keefe Bruyette
Houlihan Lokey downgraded to Market Perform from Outperform at Keefe Bruyette
11/20/19 Morgan Stanley
Houlihan Lokey initiated with an Equal Weight at Morgan Stanley
11/01/19
Rice University-Jones Graduate School of Business to hold a summit
HLI Houlihan Lokey
$59.90 /

-2.57 (-4.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.